We provide you with 20 years of free, institutional-grade data for EVOK stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of EVOK. Explore the full financial landscape of EVOK stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | Sale | -41 | $4.39 | $180 | 2025-01-30 |
| Gonyer David A | Sale | -72,000 | $2.9 | $208,800 | 2020-12-14 |
| D'Onofrio Matthew J | Sale | -46,000 | $2.95 | $135,700 | 2020-12-14 |
| D'Onofrio Matthew J | Derivatives Exercise | 46,000 | 2020-12-11 | ||
| Gonyer David A | Derivatives Exercise | 72,000 | 2020-12-11 | ||
| D'Onofrio Matthew J | Grant, award...etc | 25,000 | $0.85 | 2020-03-03 | |
| LVP GP III, LLC | Open Market Purchase | 500,000 | $2.35 | 2018-08-21 | |
| WIDDER KENNETH J | Open Market Purchase | 10,465 | $2.9 | 2017-02-24 | |
| WIDDER KENNETH J | Open Market Purchase | 20,930 | $2.9 | 2017-02-24 | |
| WIDDER KENNETH J | Open Market Purchase | 418,605 | $2.9 | 2017-02-24 | |
| DP VII ASSOCIATES LP | Sale | -5,880 | $4.7 | $27,636 | 2016-05-27 |
| DOMAIN PARTERS VII L P | Sale | -344,120 | $4.7 | $1,617,364 | 2016-05-27 |
| DOMAIN PARTERS VII L P | Sale | -5,095 | $5.2 | $26,494 | 2016-04-27 |
| DP VII ASSOCIATES LP | Sale | -82 | $5.2 | $426 | 2016-04-27 |
| DOMAIN PARTERS VII L P | Sale | -41,478 | $5.36 | $222,322 | 2016-04-21 |
| DP VII ASSOCIATES LP | Sale | -708 | $5.36 | $3,795 | 2016-04-21 |
| DP VII ASSOCIATES LP | Sale | -75 | $5.22 | $392 | 2016-04-13 |
| DOMAIN PARTERS VII L P | Sale | -4,348 | $5.22 | $22,697 | 2016-04-13 |
| DP VII ASSOCIATES LP | Sale | -874 | $5.22 | $4,562 | 2016-04-08 |
| DOMAIN PARTERS VII L P | Sale | -51,004 | $5.22 | $266,241 | 2016-04-08 |
| DP VII ASSOCIATES LP | Sale | -202 | $7.02 | $1,418 | 2015-08-20 |
| DOMAIN PARTERS VII L P | Sale | -11,836 | $7.02 | $83,089 | 2015-08-20 |
| DP VII ASSOCIATES LP | Sale | -857 | $7.78 | $6,667 | 2015-04-16 |
The information provided in this report about EVOK stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Evoke Pharma, Inc(NASDAQ:EVOK) 
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase III clinical trials to treat sym...
Website: http://www.evokepharma.com
Founded: 2007
Full Time Employees: 5
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic